Lepu Medical Technology (Beijing) Co., Ltd.

SZSE:300003 Stock Report

Market Cap: CN¥20.0b

Lepu Medical Technology (Beijing) Future Growth

Future criteria checks 3/6

Lepu Medical Technology (Beijing) is forecast to grow earnings and revenue by 28.2% and 11.9% per annum respectively. EPS is expected to grow by 27.7% per annum. Return on equity is forecast to be 7.4% in 3 years.

Key information

28.2%

Earnings growth rate

27.7%

EPS growth rate

Medical Equipment earnings growth25.5%
Revenue growth rate11.9%
Future return on equity7.4%
Analyst coverage

Low

Last updated19 Dec 2024

Recent future growth updates

Lepu Medical Technology (Beijing) Co., Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Oct 28
Lepu Medical Technology (Beijing) Co., Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Earnings Miss: Lepu Medical Technology (Beijing) Co., Ltd. Missed EPS By 56% And Analysts Are Revising Their Forecasts

Aug 27
Earnings Miss: Lepu Medical Technology (Beijing) Co., Ltd. Missed EPS By 56% And Analysts Are Revising Their Forecasts

Recent updates

Lepu Medical Technology (Beijing) (SZSE:300003) Is Reinvesting At Lower Rates Of Return

Dec 03
Lepu Medical Technology (Beijing) (SZSE:300003) Is Reinvesting At Lower Rates Of Return

Here's Why Lepu Medical Technology (Beijing) (SZSE:300003) Can Manage Its Debt Responsibly

Nov 15
Here's Why Lepu Medical Technology (Beijing) (SZSE:300003) Can Manage Its Debt Responsibly

Lepu Medical Technology (Beijing) Co., Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Oct 28
Lepu Medical Technology (Beijing) Co., Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Investors Still Aren't Entirely Convinced By Lepu Medical Technology (Beijing) Co., Ltd.'s (SZSE:300003) Earnings Despite 33% Price Jump

Oct 18
Investors Still Aren't Entirely Convinced By Lepu Medical Technology (Beijing) Co., Ltd.'s (SZSE:300003) Earnings Despite 33% Price Jump

Investors Give Lepu Medical Technology (Beijing) Co., Ltd. (SZSE:300003) Shares A 26% Hiding

Sep 02
Investors Give Lepu Medical Technology (Beijing) Co., Ltd. (SZSE:300003) Shares A 26% Hiding

News Flash: 7 Analysts Think Lepu Medical Technology (Beijing) Co., Ltd. (SZSE:300003) Earnings Are Under Threat

Aug 31
News Flash: 7 Analysts Think Lepu Medical Technology (Beijing) Co., Ltd. (SZSE:300003) Earnings Are Under Threat

Earnings Miss: Lepu Medical Technology (Beijing) Co., Ltd. Missed EPS By 56% And Analysts Are Revising Their Forecasts

Aug 27
Earnings Miss: Lepu Medical Technology (Beijing) Co., Ltd. Missed EPS By 56% And Analysts Are Revising Their Forecasts

Lepu Medical Technology (Beijing) (SZSE:300003) Might Be Having Difficulty Using Its Capital Effectively

Aug 16
Lepu Medical Technology (Beijing) (SZSE:300003) Might Be Having Difficulty Using Its Capital Effectively

Lepu Medical Technology (Beijing)'s (SZSE:300003) Dividend Is Being Reduced To CN¥0.3314

Jun 23
Lepu Medical Technology (Beijing)'s (SZSE:300003) Dividend Is Being Reduced To CN¥0.3314

Lepu Medical Technology (Beijing) (SZSE:300003) Seems To Use Debt Quite Sensibly

May 31
Lepu Medical Technology (Beijing) (SZSE:300003) Seems To Use Debt Quite Sensibly

Capital Allocation Trends At Lepu Medical Technology (Beijing) (SZSE:300003) Aren't Ideal

May 13
Capital Allocation Trends At Lepu Medical Technology (Beijing) (SZSE:300003) Aren't Ideal

Lepu Medical Technology (Beijing) (SZSE:300003) Has A Pretty Healthy Balance Sheet

Feb 28
Lepu Medical Technology (Beijing) (SZSE:300003) Has A Pretty Healthy Balance Sheet

Earnings and Revenue Growth Forecasts

SZSE:300003 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20268,3571,432N/A1,7934
12/31/20257,3511,243N/A1,6495
12/31/20246,422980N/A2,1124
9/30/20246,506707159810N/A
6/30/20247,0629943031,008N/A
3/31/20247,4651,1434881,266N/A
12/31/20237,9801,258146990N/A
9/30/20239,1071,7476421,573N/A
6/30/20239,5771,8977941,754N/A
3/31/202310,4982,2541,3202,208N/A
12/31/202210,6092,2041,8852,791N/A
9/30/20229,7871,6081,6112,558N/A
6/30/20229,4731,2621,1182,106N/A
3/31/202210,4601,5391,2112,212N/A
1/1/202210,6601,7192,0783,062N/A
9/30/202110,2861,7501,9542,812N/A
6/30/202110,3212,3872,2693,086N/A
3/31/20219,1212,1442,5673,284N/A
12/31/20208,0391,8021,4902,090N/A
9/30/20208,3032,0861,7002,312N/A
6/30/20208,1121,7101,8992,424N/A
3/31/20207,5841,5261,2941,839N/A
12/31/20197,7961,7251,4271,990N/A
9/30/20197,6521,6871,1521,834N/A
6/30/20197,3231,5649981,669N/A
3/31/20196,7991,4988771,557N/A
12/31/20186,3561,2194291,501N/A
9/30/20185,8321,3043611,241N/A
6/30/20185,3101,214N/A1,063N/A
3/31/20184,942970N/A954N/A
12/31/20174,538899N/A913N/A
9/30/20174,234874N/A772N/A
6/30/20173,974797N/A728N/A
3/31/20173,701734N/A770N/A
12/31/20163,468679N/A692N/A
9/30/20163,318649N/A778N/A
6/30/20163,113610N/A693N/A
3/31/20162,938569N/A509N/A
12/31/20152,769521N/A436N/A
9/30/20152,419520N/A374N/A
6/30/20152,208500N/A363N/A
3/31/20151,934458N/A324N/A
12/31/20141,669423N/A348N/A
9/30/20141,578405N/A277N/A
6/30/20141,490385N/A284N/A
3/31/20141,375362N/A330N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300003's forecast earnings growth (28.2% per year) is above the savings rate (2.8%).

Earnings vs Market: 300003's earnings (28.2% per year) are forecast to grow faster than the CN market (25% per year).

High Growth Earnings: 300003's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 300003's revenue (11.9% per year) is forecast to grow slower than the CN market (13.5% per year).

High Growth Revenue: 300003's revenue (11.9% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 300003's Return on Equity is forecast to be low in 3 years time (7.4%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/04 04:05
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Lepu Medical Technology (Beijing) Co., Ltd. is covered by 26 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Shuchang LiuChangjiang Securities Co. LTD.
Pei ChengChina Galaxy Securities Co., Ltd.
Yuan GaoChina International Capital Corporation Limited